Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
- Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)Active Not Recruiting
Sponsor: European Myeloma Network B.V.
Multiple Myeloma
Belgium, Czechia, Germany, Greece, Italy +3 more
Sponsor: Northwestern University
Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) · Smell Loss
United States
Sponsor: M.D. Anderson Cancer Center
Multiple Myeloma
United States
Sponsor: Sanofi
Rheumatoid Arthritis
United States
Sponsor: Sanofi
Ulcerative Colitis
United States, Canada, Georgia, Japan, Lithuania +3 more
- Isatuximab as Upfront Therapy for the Treatment of High Risk AL AmyloidosisActive Not Recruiting
Sponsor: Emory University
AL Amyloidosis
United States
- Actual Use Trial of Tadalafil 5 mgCompleted
Sponsor: Sanofi
Erectile Dysfunction
United States
- Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic DermatitisCompleted
Sponsor: Sanofi
Atopic Dermatitis
United States, Canada, Chile, Czechia, Germany +2 more
Sponsor: Sanofi
Chronic Inflammatory Demyelinating Polyneuropathy
United States, Argentina, Belgium, Brazil, Canada +18 more
Sponsor: American Thrombosis and Hemostasis Network
Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder · Hemophilia
United States
- Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPEnrolling By Invitation
Sponsor: Sanofi
Polyneuropathy, Inflammatory Demyelinating, Chronic
United States, Argentina, Brazil, Canada, Chile +16 more
- Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3Active Not Recruiting
Sponsor: Sanofi
Gaucher's Disease Type III
United States, Argentina, Canada, China, France +6 more
- Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)Active Not Recruiting
Sponsor: Regeneron Pharmaceuticals
Chronic Rhinosinusitis With Nasal Polyposis
United States, Canada, Germany, Italy, Japan +1 more
Sponsor: Sanofi
Chlamydial Infections
United States
- Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionActive Not Recruiting
Sponsor: Genzyme, a Sanofi Company
Gaucher Disease Type 1 · Gaucher Disease Type 3
United States, Germany, Japan, United Kingdom
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Australia, Brazil, Bulgaria +22 more
Sponsor: Sanofi
Type 2 Diabetes
India
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Argentina, Australia, Belgium, Brazil +12 more
Sponsor: Sanofi Pasteur, a Sanofi Company
Acne
United States
Sponsor: M.D. Anderson Cancer Center
Solid Tumors
United States
- TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII TherapiesNot Yet Recruiting
Sponsor: University of Texas Southwestern Medical Center
Hemophilia A · Factor VIII (FVIII)
United States
Sponsor: Sanofi
Atherosclerotic Cardiovascular Disease
United States
Sponsor: Sanofi
RSV Immunization
Czechia
Sponsor: Sanofi
Graves' Disease
Canada, Germany, Italy, Spain, United Kingdom
- A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's DiseaseNot Yet Recruiting
Sponsor: Sanofi
Dementia, Alzheimer's Type · Alzheimer's Disease